Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03471026
Other study ID # 17NI17
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 9, 2018
Est. completion date April 7, 2021

Study information

Verified date December 2020
Source Great Ormond Street Hospital for Children NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Post-operative paediatric cerebellar mutism syndrome (pCMS) is a well-recognised complication of resective surgery for brain tumours of the cerebellum and fourth ventricle in children. Occurring in around 25% of infratentorial craniotomies, it is characterised by a delayed onset of mutism and emotional lability, and may comprise motoric and cognitive cerebellar deficits. Transient mutism gives way to prolonged, and often incomplete, recovery. Neuroimaging studies are beginning to reveal anatomical and functional aberrancies in the brain of children with pCMS. The cerebellar efferent pathways are likely to be implicated as a neuroanatomical substrate in the development of pCMS, as shown by a handful of diffusion tractography studies to date. However, the pathophysiology of this condition still remains unclear. Hypoperfusion of supratentorial cortical and subcortical structures may mediate the speech and behavioural deficits seen in pCMS, and is a candidate for a causal pathophysiological mechanism. This study aims to prospectively image children with pCMS using advanced MRI techniques including diffusion tractography and arterial spin labelling, and to correlate this with clinical descriptions of the syndrome. All children referred to Great Ormond Street Hospital for Children with a posterior fossa brain tumour will be imaged pre-operatively, post-operatively and at delayed follow-up. In tandem with this, clinical assessments will be made of children post-operatively to ascertain which patients develop pCMS. In addition, anonymised advanced MRI data on healthy controls will be used as a comparator group.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date April 7, 2021
Est. primary completion date September 9, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: Age <18 Referred and operated upon within study period Brain tumour of cerebellum, IVth ventricle, brainstem undergoing craniotomy for resection (including re-do surgery) No restrictions as to tumour histology or grade (embryonal tumour / glioma / ependymoma) Informed consent given by parents Exclusion Criteria: Non-neoplastic infratentorial lesions Claustrophobia Contraindication to MRI Pregnant female Scans missing at >2 timepoints Tumour resection surgery at another hospital if no pre- or post-operative scans available

Study Design


Intervention

Diagnostic Test:
Advanced MRI sequences
Structural, diffusion and perfusion MRI sequences

Locations

Country Name City State
United Kingdom Great Ormond Street Hospital for Children London

Sponsors (1)

Lead Sponsor Collaborator
Great Ormond Street Hospital for Children NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diffusion MRI tractography To compare diffusion MRI derived tractography of the fronto-cerebellar circuitry (and associated metrics of fractional anisotropy and mean diffusivity) between patients with and without pCMS. 1 year
Primary Arterial Spin Labeling Perfusion MRI To compare cerebral blood flow (a metric derived from perfusion MRI) in frontal lobe regions between patients with and without pCMS. 1 year
Secondary Clinical measure of severity of pCMS CMS Severity Score (Robertson 2006 JNS Peds 105: 444-451):
Clinical diagnosis of pCMS Yes / No
If yes:
Time of onset
immediately post op
Days 1-2
Days 2-4
=> Day 4
Mutism
Mild (<1wk)
Moderate (1-4wks)
Severe (>4wks)
Ataxia
Mild (<1wk)
Moderate (1-4wks)
Severe (>4wks)
Hypotonia
Mild (can sit or stand by <1wk)
Moderate (can sit or stand by 1-4wks)
Severe (can sit or stand by >4wks)
Irritability
Mild (<1wk)
Moderate (1-4wks)
Severe (>4wks)
Severe = at least 2 severe features Moderate = at least 2 moderate features or 1 moderate and 1 severe Mild = anything less than above
1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02810626 - DTI & Tractography in Pediatric Tumor Surgery N/A